Ekkehard Dikomey
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
CXCR2 affects sensitization of radioresistant HPV-negative head and neck squamous cell carcinoma cells by ABT-263.
Journal: Radiation oncology (London, England)
Published: October 27, 2025
Alteration in ATR protein level does not account for the inherent radiosensitivity of HPV-positive head and neck squamous cell carcinoma.
Journal: Translational oncology
Published: April 17, 2024
Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells.
Journal: Life (Basel, Switzerland)
Published: May 08, 2023
Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines.
Journal: Cancers
Published: June 13, 2022
IL1 Pathway in HPV-Negative HNSCC Cells Is an Indicator of Radioresistance After Photon and Carbon Ion Irradiation Without Functional Involvement.
Journal: Frontiers in oncology
Published: February 18, 2022
HPV-positive HNSCC cell lines show strongly enhanced radiosensitivity after photon but not after carbon ion irradiation.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 23, 2020
In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity.
Journal: Translational oncology
Published: October 15, 2018
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.
Journal: EMBO reports
Published: October 07, 2018
Last Updated: 09/26/2026